Joe Anderson

Joe Anderson, Ph.D., is a partner at Sofinnova Partners, a leading life-sciences venture capital firm. He has over 30 years of experience in the healthcare & life science industry. Joe was a partner at Abingworth LLP, where he led venture-style investments in public companies and the formation of the firm's public equities fund. He also co-founded and was CEO at Arix Biosciences plc, a venture capital business listed on the London Stock Exchange. As an investor and active board member, he has helped companies with financings, IPOs, and M&As, including Algeta (sold to Bayer), Amarin (listed on the Nasdaq), Autolus plc (listed on the Nasdaq) and Cytos (merged with Kuros). His early career was at the Wellcome Trust where he became head of the strategy group. He then moved into equities research as a pharmaceuticals analyst at Dresdner Kleinwort Benson, and then fund management at First State Investments, before moving into venture capital in 2004.